The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2017

Filed:

Oct. 01, 2015
Applicant:

Stepan Company, Northfield, IL (US);

Inventors:

Dave R Allen, Chicago, IL (US);

Randal J Bernhardt, Antioch, IL (US);

Aaron Brown, Chicago, IL (US);

Anatoliy A Dameshek, Indian Creek, IL (US);

Brian Holland, Deerfield, IL (US);

Andrew D Malec, Irvine, CA (US);

Ronald A Masters, Glenview, IL (US);

Marshall J Nepras, Burlington, WI (US);

Patti Skelton, Winder, GA (US);

Laura Lee Whitlock, Highland Park, IL (US);

Patrick Shane Wolfe, Palatine, IL (US);

Assignee:

Stepan Company, Northfield, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 209/12 (2006.01); C07C 211/21 (2006.01); C07C 219/08 (2006.01); C07C 237/12 (2006.01); C07C 237/16 (2006.01); C07C 303/18 (2006.01); C07C 41/03 (2006.01); C07C 43/11 (2006.01); C07C 6/04 (2006.01); C07C 67/26 (2006.01); C07C 69/533 (2006.01); C07C 69/593 (2006.01); A01N 25/02 (2006.01); A01N 25/04 (2006.01); A01N 25/30 (2006.01); A01N 33/12 (2006.01); A01N 37/18 (2006.01); A01N 37/44 (2006.01); A01N 41/04 (2006.01); A61K 8/41 (2006.01); A61K 8/42 (2006.01); A61K 8/44 (2006.01); A61K 8/46 (2006.01); A61K 8/92 (2006.01); A61Q 5/12 (2006.01); A61Q 19/10 (2006.01); A62D 1/02 (2006.01); B01F 17/00 (2006.01); C07C 231/12 (2006.01); C07C 237/18 (2006.01); C08G 65/26 (2006.01); C08K 5/01 (2006.01); C08K 5/20 (2006.01); C09K 15/28 (2006.01); C11C 3/00 (2006.01); C11C 3/08 (2006.01); C11D 1/00 (2006.01); C11D 1/04 (2006.01); C11D 1/28 (2006.01); C11D 1/62 (2006.01); C11D 1/65 (2006.01); C11D 1/74 (2006.01); C11D 1/83 (2006.01); C11D 1/90 (2006.01); C11D 1/92 (2006.01); C11D 1/94 (2006.01); C11D 3/48 (2006.01); A61Q 5/02 (2006.01); C09K 8/00 (2006.01);
U.S. Cl.
CPC ...
C07C 219/08 (2013.01); A01N 25/02 (2013.01); A01N 25/04 (2013.01); A01N 25/30 (2013.01); A01N 33/12 (2013.01); A01N 37/18 (2013.01); A01N 37/44 (2013.01); A01N 41/04 (2013.01); A61K 8/416 (2013.01); A61K 8/42 (2013.01); A61K 8/44 (2013.01); A61K 8/466 (2013.01); A61K 8/92 (2013.01); A61K 8/922 (2013.01); A61Q 5/02 (2013.01); A61Q 5/12 (2013.01); A61Q 19/10 (2013.01); A62D 1/0071 (2013.01); B01F 17/0028 (2013.01); B01F 17/0057 (2013.01); C07C 6/04 (2013.01); C07C 41/03 (2013.01); C07C 43/11 (2013.01); C07C 67/26 (2013.01); C07C 69/533 (2013.01); C07C 69/593 (2013.01); C07C 209/12 (2013.01); C07C 211/21 (2013.01); C07C 231/12 (2013.01); C07C 237/18 (2013.01); C07C 303/18 (2013.01); C08G 65/2615 (2013.01); C08K 5/01 (2013.01); C08K 5/20 (2013.01); C09K 15/28 (2013.01); C11C 3/00 (2013.01); C11C 3/08 (2013.01); C11D 1/002 (2013.01); C11D 1/04 (2013.01); C11D 1/28 (2013.01); C11D 1/62 (2013.01); C11D 1/652 (2013.01); C11D 1/74 (2013.01); C11D 1/83 (2013.01); C11D 1/90 (2013.01); C11D 1/92 (2013.01); C11D 1/94 (2013.01); C11D 3/48 (2013.01); A61K 2800/805 (2013.01); C09K 8/00 (2013.01);
Abstract

Esteramine compositions and their derivatives are disclosed. The esteramines comprise a reaction product of a metathesis-derived C-Cmonounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives with a tertiary alkanolamine. Derivatives made by quaternizing, sulfonating, alkoxylating, sulfating, and/or sulfitating the esteramines are also disclosed. In one aspect, the ester derivative of the C-Cmonounsaturated acid or octadecene-1,18-dioic acid is a lower alkyl ester. In other aspects, the ester derivative is a modified triglyceride made by self-metathesis of a natural oil or an unsaturated triglyceride made by cross-metathesis of a natural oil with an olefin. The esteramines and derivatives are valuable for a wide variety of end uses, including cleaners, fabric treatment, hair conditioning, personal care (liquid cleansing products, conditioning bars, oral care products), antimicrobial compositions, agricultural uses, and oil field applications.


Find Patent Forward Citations

Loading…